Magnetic resonance imaging detected prostate evasive anterior tumours: Further insights

Canadian Urological Association Journal

Volumn 9, Issue 5-6, 2015, Pages E267-E272

  Al Edwan, Ghazi ^a   Ghai, Sangeet ^a   Margel, David ^a   Kulkarni, Girish ^a   Hamilton, Rob ^a   Toi, Ants ^a   Haidar, Masoom A ^a   Finelli, Antonio ^a   Fleshner, Neil E ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER STAGING; GLEASON SCORE; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; LOCAL THERAPY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE BIOPSY; PROSTATE EVASIVE ANTERIOR TUMOR; PROSTATE TUMOR; PROSTATECTOMY; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 84929327692     PISSN: 19116470     EISSN: 19201214     Source Type: Journal    
DOI: 10.5489/cuaj.2562     Document Type: Article

References (25)

1. Sanda MG, Dunn RL, Michalaski J, et al. Quality of life and satisfaction with outcome among prostate cancer survivors. N Engl J Med 2008;358:1250-61. http://dx.doi.org/10.1056/NEJMoa074311
2. McNeal JE. The zonal anatomy of the prostate. Prostate 1981;2:35-49. http://dx.doi.org/10.1002/ pros.2990020105
3. Stamey TA, Dietrick DD, Issa MM. Large, organ confined, impalpable transition zone prostate cancer: Association with metastatic levels of prostate specific antigen. J Urol 1993;149:510-5.
4. Noguchi M, Stamey TA, Neal JE, et al. An analysis of 148 consecutive transition zone cancers: Clinical and histological characteristics. J Urol 2000;163:1751-5. http://dx.doi.org/10.1016/S0022-5347(05)67535-0
5. Panebianco V, Barchetti F, Sciarra A, et al., Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: A randomized study. Urol Oncol 2015;33:17.e1-7. http://dx.doi.org/10.1016/j.urolonc.2014.09.013. Epub 2014 Nov 11.
6. Puech P, Rouvière O, Renard-Penna R, et al. Prostate cancer diagnosis: Multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy-prospective multicenter study. Radiology 2013;268:461-9. http://dx.doi.org/10.1148/radiol.13121501
7. de Rooij M, Hamoen EHJ, Fütterer JJ, et al. Accuracy of multiparametric MRI for prostate cancer detection: A meta-analysis. AJR Am J Roentgenol 2014;202:343-51. http://dx.doi.org/10.2214/AJR.13.11046
8. Abd-Alazeez M, Ahmed HU, Arya M, et al. The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level-can it rule out clinically significant prostate cancer? Urol Oncol 2014;32:45. e17-22.
9. Shakir NA, George AK, Siddiqui MM, et al. Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy. J Urol 2014;192:1642-9. http://dx.doi.org/10.1016/j.juro.2014.08.002
10. Lawrentschuk N, Haider MA, Daljeet N, et al. Prostatic evasive anterior tumors: The role of magnetic resonance imaging. BJU Int 2010;105:1231-6. http://dx.doi.org/10.1111/j.1464-410X.2009.08938.x
11. Margel D, Yap SA, Lawrentschuk N, et al. Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: A prospective cohort study. J Urol 2012;187:1247-52. http://dx.doi.org/10.1016/j.juro.2011.11.112
12. Kurhanewicz J, Vigneron D, Carroll P, et al. Multiparametric magnetic resonance Imaging in prostate cancer: Present and future. Curr Opin Urol 2008;18:71-7. http://dx.doi.org/10.1097/ MOU.0b013e3282f19d01
13. Weinreb JC, Blume JD, Coakley FV, et al. Prostate cancer: Sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy-results of ACRIN prospective multi-institutional clinicopathologic study. Radiology 2009;251:122-33. http://dx.doi.org/10.1148/radiol.2511080409
14. Haider MA, van der Kwast TH, Tanguay J, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 2007;189:323-8. http://dx.doi.org/10.2214/ AJR.07.2211
15. Akin O, Sala E, Moskowitz CS, et al. Transition zone prostate cancers: Features, detection, localization, and staging at endorectal MR imaging. Radiology 2006;239:784-92. http://dx.doi.org/10.1148/ radiol.2392050949
16. Futterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer localization with dynamic contrastenhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006;241:449-58. http:// dx.doi.org/10.1148/radiol.2412051866
17. Al-Ahmadie HA, Tickoo SK, Olgac S, et al. Anterior-predominant prostatic tumors: Zone of origin and pathologic outcomes at radical prostatectomy. Am J Surg Pathol 2008;32:229-35. http://dx.doi. org/10.1097/PAS.0b013e31812f7b27
18. Hoeks CM, Vos EK, Bomers JGR, et al. Diffusion-weighted magnetic resonance imaging in the prostate transition zone: Histopathological validation using magnetic resonance-guided biopsy specimens. Invest Radiol 2013;48:693-701. http://dx.doi.org/10.1097/RLI.0b013e31828eeaf9
19. Oto A, Kayhan A, Jiang Y, et al., Prostate cancer: Differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 2010;257:715-23. http://dx.doi.org/10.1148/radiol.10100021
20. Schoots IG, Roobol MJ, Nieboer D, et al. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasoundguided biopsy: A systematic review and meta-analysis. Eur Urol 2014; http://dx.doi.org/10.1016/j. eururo.2014.11.037
21. Langer DL, van der Kwast TH, Evans AJ, et al. Intermixed normal tissue within prostate cancer: Effect on MR imaging measurements of apparent diffusion coefficient and T2-sparse versus dense cancers. Radiology 2008;249:900-8. http://dx.doi.org/10.1148/radiol.2493080236
22. Kulkarni GS, Lockwood G, Evans AJ, et al. Clinical predictors of Gleason score upgrading: Implications for patients considering watchful waiting, active surveillance, or brachytherapy. Cancer 2007;109:2432-8. http://dx.doi.org/10.1002/cncr.22712
23. Koppie TM, Bianco FJ, Kuroiwqa K, et al. The clinical features of anterior prostate cancers. BJU Int 2006;98:1167-71. http://dx.doi.org/10.1111/j.1464-410X.2006.06578.x
24. Bott SR, Young MP, Kellett MJ, et al. Contributors to the UCL Hospitals' Trust Radical Prostatectomy Database. Anterior prostate cancer: Is it more difficult to diagnose? BJU Int 2002;89:886-9. http:// dx.doi.org/10.1046/j.1464-410X.2002.02796.x
25. Lieberman D, Jeldres C, Trinh Q-D, et al. Suspected clinical T3 prostate cancer is associated with high rate of negative extended biopsies: Clinical implications. Presented at: Québec Urological Association Annual Meeting; November 14-16, 2008; Québec, Canada.